• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    25.54 Up 0.60(2.41%) Feb 27, 3:59PM EST
    |After Hours : 25.70 Up 0.16 (0.63%) Feb 27, 6:24PM EST
    Add to Portfolio
    Prev Close:24.94
    Open:25.36
    Bid:25.55 x 300
    Ask:N/A
    1y Target Est:34.78
    Beta:2.22
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:24.75 - 25.91
    52wk Range:10.76 - 28.45
    Volume:2,299,629
    Avg Vol (3m):2,204,520
    Market Cap:2.29B
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLDX

    Comparison

    Symbol% ChgMkt Cap
    CLDXUp 2.41%2.29B
    DNDN 0.00%N/A
    LLYUp 0.20%74.42B
    RHHBYUp 0.80%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):623.21
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.48
    Quarterly EPS Est (Mar-15) :-0.37
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback